Transformations and Tensions in Health Leadership

This chapter examines major changes at the NIH following a significant purge of key officials linked to the COVID vaccine development, including controversial firings. It critiques the regulatory landscape's preparedness against biological threats and highlights the intertwined relationships between health organizations and pharmaceutical companies. The narrative raises critical concerns about the integrity of vaccine approvals and the implications for public health amidst ongoing debates over safety and ethics.